Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Boehringer Ingelheim Aktiebolag
AB
Active
Org 5561030650
Hammarby Allé 29, 120 32
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1966
72 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Boehringer Ingelheim Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
383M
765M
1B
2B
936M
2020
985M
2021
1.1B
2022
1.3B
2023
1.3B
2024
EBITDA
SEK millions
0M
12M
24M
36M
48M
41M
2020
41M
2021
42M
2022
37M
2023
39M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
935 867
985 180
1 133 029
1 258 722
1 331 031
Staff expenses
—
—
—
—
—
EBITDA
41 032
40 523
41 566
37 341
38 581
Depreciation & amort.
−1 918
−1 900
−1 941
−1 204
−1 203
EBIT
39 114
38 623
39 625
36 137
37 378
Net financials
−725
−841
−1 696
−7 258
−12 721
Profit before tax
38 392
37 783
37 933
28 888
24 695
Tax
−8 663
−8 388
−8 824
−7 230
−4 759
Net profit
29 729
29 395
29 109
21 658
19 936
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
286 348
314 084
325 055
413 159
532 800
Equity
73 102
72 497
49 165
40 823
50 759
Long-term debt
0
0
0
0
0
Short-term debt
213 245
241 587
261 890
364 570
475 178
Total debt
213 245
241 587
261 890
364 570
475 178
Financial ratios
5-year trend
EBITDA margin
2.9%
This company
15.8%
Market median
-82% vs market
2020
2024
Equity ratio
9.5%
This company
38.2%
Market median
-75% vs market
2020
2024
Return on equity
39.3%
This company
18.4%
Market median
+114% vs market
2020
2024
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
2020
2024
Asset turnover
2.50×
This company
1.12×
Market median
+123% vs market
2020
2024
Debt / equity
9.50×
This company
0.62×
Market median
-1432% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Boehringer Ingelheim Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
